መነሻ › ኒውሮብላስቶማ › North Carolina
በNorth Carolina ለኒውሮብላስቶማ የሚደረጉ ክሊኒካዊ ጥናቶች
ለኒውሮብላስቶማ የሚደረጉ 7 ጥናቶች በNorth Carolina ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በNorth Carolina ውስጥ ያሉ ከተሞች
Official study text (English)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Mission Hospital, Asheville
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- እና 4 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እስከ እድሜ 30 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06172296Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
- Levine Children's Hospital, Charlotte
ተሳታዮችን በመፈለግ ላይደረጃ 2
እስከ እድሜ 22 · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT02559778Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
- Duke University, Durham
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ1 እስከ 21 · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06540963Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Mission Hospital, Asheville
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- እና 3 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
365 Days – 30 Years · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT03126916Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
- Levine Children's Hospital, Charlotte
- Duke University, Durham
ተሳታዮችን በመፈለግ ላይደረጃ 2
12 Months – 21 Years · ሁሉም ጾታዎች · የተሻሻለው በ12 ኦገስ 2026 · NCT05489887SPEARHEAD-3 Pediatric Study
- Duke University School of Medicine, Durham
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ2 እስከ 21 · ሁሉም ጾታዎች · የተሻሻለው በ11 ኦገስ 2026 · NCT05642455Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill
ተሳታዮችን በመፈለግ ላይደረጃ 1
18 Months · ሁሉም ጾታዎች · የተሻሻለው በ27 ማርች 2026 · NCT03721068ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።